Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GBA1 | P04062 | 9/20 | 1.00 |
| ▸ | SSTR4 | P31391 | 13/20 | 0.69 |
| ▸ | SSTR2 | P30874 | 12/20 | 0.69 |
| ▸ | MEN1 | O00255 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.52 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.52 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 1/20 | 0.52 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.52 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.52 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.52 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.52 |
| ▸ | FPR1 | P21462 | 1/20 | 0.52 |
| ▸ | DRD1 | P21728 | 1/20 | 0.52 |
| ▸ | DRD5 | P21918 | 1/20 | 0.52 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.52 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.52 |
| ▸ | HTR1B | P28222 | 1/20 | 0.52 |
| ▸ | HTR2A | P28223 | 1/20 | 0.52 |
| ▸ | HTR2C | P28335 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8181562 | 0.81 | GBA1 (0.69) | GBA1SSTR4SSTR2MEN1ALDH1A1 | |
| SCHEMBL7424609 | 0.81 | SSTR4 (1.00) | GBA1SSTR4SSTR2MEN1ALDH1A1 | |
| SCHEMBL7421002 | 0.81 | GBA1 (0.68) | GBA1SSTR4SSTR2MEN1ALDH1A1 | |
| SCHEMBL7426165 | 0.79 | GBA1 (0.69) | GBA1SSTR4SSTR2MEN1ALDH1A1 | |
| SCHEMBL7428973 | 0.79 | GBA1 (0.68) | GBA1SSTR4SSTR2MEN1ALDH1A1 | |
| SCHEMBL7418909 | 0.78 | GBA1 (0.67) | GBA1SSTR4SSTR2MEN1ALDH1A1 | |
| SCHEMBL7420183 | 0.75 | SSTR4 (1.00) | GBA1SSTR4SSTR2MEN1ALDH1A1 | |
| SCHEMBL8186195 | 0.72 | SSTR4 (0.74) | GBA1SSTR4SSTR2MEN1ALDH1A1 | |
| SCHEMBL8525622 | 0.72 | SSTR4 (0.68) | GBA1SSTR4SSTR2MEN1ALDH1A1 | |
| SCHEMBL7417784 | 0.72 | SSTR4 (0.74) | GBA1SSTR4SSTR2MEN1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6083960-A | FOR TREATING MEDICAL DISORDERS RELATED TO BINDING TO HUMAN SOMATOSTATIN RECEPTOR SUBTYPES; TREATMENT OF TYPE I DIABETES, TYPE II DIABETES, ENDOCRINE TUMORS, EXOCRINE TUMORS, DWARFISM, OTHER GROWTH DISORDERS, ARTERIOSCLEROSIS | NOVO NORDISK A/S (DK) | 2000-07-04 | — | — | US | claimed |
| EP-0937065-A1 | CONSTRAINED SOMATOSTATIN AGONISTS AND ANTAGONISTS | NOVO NORDISK A/S (DK) | 1999-08-25 | — | — | EP | claimed |
| WO-1998018786-A1 | CONSTRAINED SOMATOSTATIN AGONISTS AND ANTAGONISTS | NOVO NORDISK A/S (DK) | 1998-05-07 | — | — | WO | claimed |
| US-6083960-A | FOR TREATING MEDICAL DISORDERS RELATED TO BINDING TO HUMAN SOMATOSTATIN RECEPTOR SUBTYPES; TREATMENT OF TYPE I DIABETES, TYPE II DIABETES, ENDOCRINE TUMORS, EXOCRINE TUMORS, DWARFISM, OTHER GROWTH DISORDERS, ARTERIOSCLEROSIS | NOVO NORDISK A/S (DK) | 2000-07-04 | — | — | US | disclosed |
| US-6020349-A | Constrained somatostatin agonists and antagonists | NOVO NORDISK A/S (DK) | 2000-02-01 | — | — | US | disclosed |